GLP1 hair loss usually happens because the body is adapting to a major shift, not because hair suddenly became the target
That can amount to more than $22,000 in medication costs per year
Sustainable financing strategies become mandatory for patients considering long-term GLP-1 therapy protocols
Semaglutide might increase this risk by causing fluid loss
Because the vast array of molecular and cellular mechanisms modulated by these two new drug classes often intercept in pathophysiological background of chronic cardiovascular and neurodegenerative diseases, it is possible that any future new anti-diabetic drug may be also relevant for cardiometabolic and cognitive decline, independently from the anti-diabetic action
To bridge this knowledge gap, this review aims to first identify common pathological targets (key biomarkers and gut microbiota) across AD, T2DM, and PCOS, and then critically evaluate the evidence for how DSS and its active constituent precisely interact with them
.png)
